NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
LUNG EPICHECK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
LUNG EPICHECK
ST13
US500000097842045Class
5, 10, 44
Filing
97842045
Registration
7575465
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
11/26/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 10, 44
Filing date
03/16/2023
Registration date
11/26/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Rehovot, IL
Examiner
JOHNSON, CLINTON
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Nucleix Limited
Representatives
Jennifer Sheehan Anderson BRIDGE INTELLECTUAL PROPERTY SERVICES PLLC
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic test kits for medical and clinical use comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancerprecancerous conditions and chronic obstructive pulmonary disease (COPD) for testing of bodily fluids for use in disease detectioncancerprecancerous conditions and chronic obstructive pulmonary disease (COPD); medical diagnostic assay kits comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancerprecancerous conditions and chronic obstructive pulmonary disease (COPD) for testing of bodily fluids for use in disease detectioncancerprecancerous conditions and chronic obstructive pulmonary disease (COPD); medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancerprecancerous conditions and chronic obstructive pulmonary disease (COPD) in the field of cancer detection and detection of chronic obstructive pulmonary disease (COPD)
Class 10
Medical apparatus for medical diagnostic testing in the fields of cancer and chronic obstructive pulmonary disease (COPD)
Class 44
Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD); providing cancer screening services; providing medical screening services for chronic obstructive pulmonary disease (COPD); providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD)
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2024
ALIE
ASSIGNED TO LIE
08/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/04/2024
GNRT
NON-FINAL ACTION E-MAILED
01/04/2024
CNRT
NON-FINAL ACTION WRITTEN
01/04/2024
DOCK
ASSIGNED TO EXAMINER
12/13/2023
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
05/30/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2023
NWAP
NEW APPLICATION ENTERED
03/20/2023
Continuous trademark protection
Get notified about every new filing that threatens LUNG EPICHECK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.